Sanofi-GSK COVID vax shows strong immune responses in Phase 2 trial

A COVID-19 vaccine developed by pharmaceutical giants Sanofi and Glaxo Smith Kline (GSK) has shown strong rates of neutralising antibody responses against the infectious Coronavirus disease in the Phase-II trial.



from Zee News :Zee News - Health https://ift.tt/3hyEotX

Credit -

No comments:

Post a Comment

Parental domestic violence in childhood linked to mental illness in adulthood: Study

The study found that one-fifth (22.5 percent) of adults who were exposed to chronic parental domestic violence during childhood developed a ...